Ocular Implants Market by Type (Intraocular Lenses, Ocular Prosthesis, Glaucoma Implants, Corneal Implants, and Others), Application (Glaucoma Surgery, Ocuplasty, Others), End User (Eye Specialty Clinics, Eye Institutes, Hospitals): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00027065 | Pages: 100 | Industry: Medical Device | Date: Oct 2022 | Type: Global

The market crossed the US$ 12.54 billion mark in 2022 and is expected to hit US$ 18.67 billion by 2030, recording a CAGR of 5.1% during the forecast period.

The surge in the number of corneal diseases will drive the growth of the market.

The increasing number of corneal diseases is expected to increase demand for ocular implants, driving the global market growth over the forecast period. For instance, according to the World Health Organization (WHO), corneal blindness is one of the major causes of visual deficiency after cataracts, glaucoma, and age-related macular degeneration (AMD) and 4th cause of blindness globally (5.1%). Moreover, according to WHO, cornea diseases affect around 30 million people, and about two million new cases of corneal dysfunction are diagnosed yearly.

Within the report, the market is categorized into type, application, and end user. Based on type the market is segmented into intraocular lenses, ocular prostheses, glaucoma implants, corneal implants, and others. Based on application the market is segmented into glaucoma surgery, ocuplasty, and others. Based on end-user the market is segmented into eye specialty clinics, eye institutes, and hospitals. Geographically, the market is sub-segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.  

Get more information on this report :

Advancements in technology will empower the growth of the market.

The market has witnessed a wide number of technological advancements. For instance, Alcon, the global leader in eye care committed to help people see brilliantly, highlighted a robust scientific program including new data and advancements across its portfolio of innovations in cataract, refractive and retina surgery during the American Academy of Ophthalmology (AAO). Additionally, the advent of microinvasive devices for patients suffering from glaucoma is expected to drive the market. Other such innovations include advance intraocular lenses and corneal implants that addresses the concerns of already existing implantable devices. These advanced technologies to treat ocular disorders and diseases expected to surge the market sales during the forecast years.

Increasing number of product launches will accelerate the market growth.

The increasing number of product launches is expected to drive the market. For instance, In April 2022, STAAR SURGICAL announced the launch of EVO Vision Implantable Collamer Lens at the American Society of Cataract and Refractive Surgery Annual Meeting (ASCRS) in Washington, D.C. On August 13, 2020 – Johnson & Johnson Vision, a global leader in eye health, announced Health Canada approval and July availability of its TECNIS Synergy and TECNIS Eyhance IOLs to the Canadian market. Cataracts are the leading cause of blindness globally4, with more than 90 percent of people developing cataracts by age 65.5. The TECNIS Synergy, originally launched in September 2019, is a breakthrough solution that delivers continuous high-contrast vision from far through near, allowing patients to see at their ideal distances and provide superior low-light contrast benefits from day to night. The TECNIS Eyhance, originally launched in February 2019, is a next-generation intraocular lens that goes beyond the expectations of the monofocal category to allow patients to experience high-quality vision at both intermediate and far distances.

Recent strategic developments in ocular implants market

The ocular implants market has undergone several significant developments, and a few of these have been mentioned below:

  • On 18 March 2019, Alcon, the global leader in eye care and a division of Novartis, announced that it has acquired PowerVision, Inc., a US-based medical device development company focused on creating fluid-based intraocular lens implants.
  • On 6 April 2022, STAAR Surgical Announced its first implants of EVO Visian ICL in the U.S. The Company also announced its program of meetings and presentations during the American Society of Cataract and Refractive Surgery Annual Meeting (ASCRS) in Washington, D.C.
  • On 11 August 2020 Johnson & Johnson Vision Launches TECNIS Synergy and TECNIS Eyhance Intraocular Lenses (IOLs) to treat cataracts in Canada.

Several players drive the ocular implants market by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Novartis AG, ZEISS International, Bausch & Lomb Incorporated., Pfizer Inc.; Johnson & Johnson Services, Inc.; MORCHER GmbH; OSD Medical GmbH; Ophtec BV, BVI Holdings Limited, STAAR Surgical Company. are among the prominent players operating in the market.

Target audience for the report:

  • Raw material providers
  • Government bodies, such as regulating authorities and policy makers
  • End users
  • Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented based on:

  • Type:
    • Intraocular Lenses
    • Ocular Prosthesis
    • Glaucoma Implants
    • Corneal Implants
    • Others
  • Application
    • Glaucoma Surgery
    • Ocuplasty
    • Others
  • End-user:
    • Eye Specialty Clinics
    • Eye Institutes
    • Hospitals
  • Region
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa
  • Companies profiled
    • Novartis AG
    • ZEISS International
    • Bausch & Lomb Incorporated
    • Pfizer Inc.
    • Johnson & Johnson Services, Inc
    • MORCHER GMBH
    • OSD Medical GmbH
    • Ophtec BV
    • BVI Holdings Limited
    • STAAR Surgical Company

The List of Companies
- Novartis AG
- ZEISS International
- Bausch & Lomb Incorporated
- Pfizer Inc.
- Johnson & Johnson Services, Inc
- MORCHER GMBH
- OSD Medical GmbH
- Ophtec BV
- BVI Holdings Limited
- STAAR Surgical Company


Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$1500
Site License
$2500
Enterprise License
$3500